1994
DOI: 10.1128/jcm.32.4.1115-1118.1994
|View full text |Cite
|
Sign up to set email alerts
|

Fluconazole-resistant recurrent oral candidiasis in human immunodeficiency virus-positive patients: persistence of Candida albicans strains with the same genotype

Abstract: Thirty human immunodeficiency virus-positive patients carrying Candida albicans in their oropharynx were treated with fluconazole and were monitored for 90 to 570 days. Fluconazole-resistant C. albicans (MIC, >32 ,ig/ml) appeared only in seven patients and only after 90 days of treatment corresponding to a total dose of more than 10 g. Resistance was not associated with resistance to other azole derivatives. Susceptible and resistant strains from each patient had the same genotype (as defined by electrophoreti… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

3
69
1

Year Published

1995
1995
2019
2019

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 189 publications
(73 citation statements)
references
References 27 publications
3
69
1
Order By: Relevance
“…Genomic DNA from C. albicans strains was isolated as described previously (Millon et al, 1994). Southern hybridization with enhanced chemiluminescence-labelled probes was performed with the ECL labelling and detection kit provided by Amersham (Braunschweig, Germany) according to the instructions of the manufacturer.…”
Section: Southern and Northern Hybridizationmentioning
confidence: 99%
“…Genomic DNA from C. albicans strains was isolated as described previously (Millon et al, 1994). Southern hybridization with enhanced chemiluminescence-labelled probes was performed with the ECL labelling and detection kit provided by Amersham (Braunschweig, Germany) according to the instructions of the manufacturer.…”
Section: Southern and Northern Hybridizationmentioning
confidence: 99%
“…Genomic DNA from C. albicans was isolated as described previously (Millon et al, 1994). DNA (10 µg) was digested with EcoRI, separated on a 1% agarose gel and, after ethidium bromide staining, transferred by vacuum blotting onto a nylon membrane and fixed by UV cross-linking.…”
Section: Isolation Of Genomic Dna and Southern Hybridizationmentioning
confidence: 99%
“…Of these drugs, fluconazole has the most attractive pharmacodynamic profile with a low level of toxicity and a high degree of bioavailability, including the capacity to produce high concentrations of the active drug in saliva, cerebrospinal fluid and urine (16). Nevertheless, longterm prophylaxis with fluconazole, either intermittently or continuously, has resulted in an increasing number of patients with fluconazole-resistant candidiasis (6,(23)(24)(25)(26)(27)(28)(29). For instance, of HIV-infected patients with symptomatic candidiasis, 80-100% recover within 5-10 days of fluconazole therapy (2,4,6,10) although 20-100% of such patients relapse within a month once treatment is stopped (2,3,6,10).…”
mentioning
confidence: 99%